Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct pioglitazone in the treatment of bipolar disorder
2014-003803-31Phase 3Active
- Sponsor
- Hospital Universitario Araba
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in bipolar disorder (BD) (2 arms), sponsored by Hospital Universitario Araba. Primary endpoint: Change in clinical condition (CGI-BP-M). Started Oct 2014; status: active.
02
Drugs
pioglitazone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2014-003803-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003803-31.